SARS-COV-2 as an artificial creation: scientific arguments and counterarguments.
作者信息
Yee Shermaine, Tan Ching Siang, Khan Abdullah, Lee Kah Seng, Goh Bey Hing, Ming Long Chiau
机构信息
Faculty of Medicine, Quest International University Perak, Ipoh, Perak, Malaysia.
School of Pharmacy, KPJ Healthcare University College, Nilai, Negeri Sembilan, Malaysia.
出版信息
J Med Life. 2021 Jan-Mar;14(1):118-120. doi: 10.25122/jml-2020-0175.
Abstract
摘要
相似文献
1
SARS-COV-2 as an artificial creation: scientific arguments and counterarguments.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）作为人工产物：科学论据与反驳论据
J Med Life. 2021 Jan-Mar;14(1):118-120. doi: 10.25122/jml-2020-0175.
2
Scaling up interactive argumentation by providing counterarguments with a chatbot.通过使用聊天机器人提供反驳观点来扩大交互式论证的规模。
Nat Hum Behav. 2022 Apr;6(4):579-592. doi: 10.1038/s41562-021-01271-w. Epub 2022 Feb 14.
3
The ethics of animal research: a survey of pediatric health care workers.动物研究的伦理：儿科医护人员的一项调查
Philos Ethics Humanit Med. 2014 Dec 30;9:20. doi: 10.1186/s13010-014-0020-7.
4
The ethics of animal research: a survey of the public and scientists in North America.动物研究的伦理：对北美公众和科学家的一项调查
BMC Med Ethics. 2016 Mar 29;17:17. doi: 10.1186/s12910-016-0100-x.
5
Respect for individual autonomy and a collective benefit: Arguments in favor of compulsory SARS-CoV-2 vaccination among health care professionals.尊重个人自主权和集体利益：支持医护人员强制接种 SARS-CoV-2 疫苗的观点。
Arch Argent Pediatr. 2021 Aug;119(4):e298-e302. doi: 10.5546/aap.2021.eng.e298.
6
Negotiation as a form of persuasion: arguments in first offers.谈判作为一种说服形式：首次报价中的论点。
J Pers Soc Psychol. 2011 Aug;101(2):245-55. doi: 10.1037/a0023331.
7
Why inconsistency arguments fail: a response to Shaw.为何不一致性论证不成立：对肖的回应。
New Bioeth. 2022 Jun;28(2):139-151. doi: 10.1080/20502877.2022.2070960. Epub 2022 May 9.
8
There is no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (DOI: 10.1002/bies.202000240).没有 SARS-CoV-2 实验室起源的证据：Segreto 和 Deigin 的回应（DOI：10.1002/bies.202000240）。
Bioessays. 2021 May;43(5):e2000325. doi: 10.1002/bies.202000325. Epub 2021 Mar 9.
9
Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases.SARS-CoV-2 相关疾病的影像学诊断与病理学
Int J Mol Sci. 2020 Sep 22;21(18):6960. doi: 10.3390/ijms21186960.
10
Global Scientific Research on SARS-CoV-2 Vaccines: A Bibliometric Analysis.关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗的全球科学研究：文献计量分析
Cell J. 2021 Oct;23(5):523-531. doi: 10.22074/cellj.2021.7794. Epub 2021 Oct 30.
引用本文的文献
1
Global health security in the post-COVID-19 era: threats, preparation, and response.新冠疫情后时代的全球卫生安全：威胁、防范与应对
Osong Public Health Res Perspect. 2025 Apr;16(2):116-125. doi: 10.24171/j.phrp.2025.0037. Epub 2025 Apr 4.
2
ABCA3 and LZTFL1 Polymorphisms and Risk of COVID-19 in the Czech Population.ABCA3 和 LZTFL1 多态性与捷克人群 COVID-19 风险的关联。
Physiol Res. 2023 Aug 31;72(4):539-543. doi: 10.33549/physiolres.935108.
3
Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?探索针对 SARS-CoV-2 及其变体的 COVID-19 候选疫苗：我们的立场在哪里，我们的前进方向在哪里？
Hum Vaccin Immunother. 2021 Dec 2;17(12):4714-4740. doi: 10.1080/21645515.2021.1995283.
本文引用的文献
1
Origin of novel coronavirus causing COVID-19: A computational biology study using artificial intelligence.导致COVID-19的新型冠状病毒的起源：一项使用人工智能的计算生物学研究。
Mach Learn Appl. 2022 Sep 15;9:100328. doi: 10.1016/j.mlwa.2022.100328. Epub 2022 May 16.
2
The known unknowns of T cell immunity to COVID-19.新冠病毒 T 细胞免疫的已知未知数。
Sci Immunol. 2020 Nov 18;5(53). doi: 10.1126/sciimmunol.abe8063.
3
Insights into the COVID-19 pandemic: Origin, pathogenesis, diagnosis, and therapeutic interventions.对新冠疫情的洞察：起源、发病机制、诊断及治疗干预措施。
Front Biosci (Elite Ed). 2021 Jan 1;13(1):117-139. doi: 10.2741/874.
4
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.SARS-CoV-2 与 ACE2 受体结合的分子相互作用和抑制。
Nat Commun. 2020 Sep 11;11(1):4541. doi: 10.1038/s41467-020-18319-6.
5
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.新冠病毒（COVID-19）中 Bcl-6 表达的滤泡辅助性 T 细胞和生发中心的缺失。
Cell. 2020 Oct 1;183(1):143-157.e13. doi: 10.1016/j.cell.2020.08.025. Epub 2020 Aug 19.
6
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.
7
T cell responses in patients with COVID-19.新冠病毒肺炎患者的T细胞反应
Nat Rev Immunol. 2020 Sep;20(9):529-536. doi: 10.1038/s41577-020-0402-6. Epub 2020 Jul 29.
8
COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.新型冠状病毒肺炎：血管紧张素1-7在血管紧张素转换酶2调节中的关键作用
Ann Acad Med Singap. 2020 Jun;49(6):398-400.
9
The Origin of COVID-19 and Why It Matters.新冠病毒（COVID-19）的起源及其重要性。
Am J Trop Med Hyg. 2020 Sep;103(3):955-959. doi: 10.4269/ajtmh.20-0849.
10
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.中国浙江省 465 例新冠肺炎（COVID-19）住院病例的流行病学、临床和病毒学特征。
Influenza Other Respir Viruses. 2020 Sep;14(5):564-574. doi: 10.1111/irv.12758. Epub 2020 May 19.
Zotero 插件